Literature DB >> 9246055

Small bowel dysmotility in patients with postcholecystectomy sphincter of Oddi dysfunction.

P R Evans1, Y T Bak, J F Dowsett, R C Smith, J E Kellow.   

Abstract

Postcholecystectomy patients (N = 27) with severe recurrent biliary-like pain who had no evidence of organic disease were subdivided into those with and those without objective evidence of sphincter of Oddi dysfunction (SOD) based on two separate criteria: (1) clinical criteria-elevated liver function tests and/or amylase with pain, and/or a dilated bile duct, and/or delayed drainage at ERCP (N = 14, SOD classes I and II); and (2) abnormal biliary manometry (N = 19). Prolonged (24-48 hr) ambulant recording of duodenojejunal motor activity was performed in all patients and interdigestive small bowel motor activity compared between patient subgroups and a healthy control group. Phase II motor abnormality was more frequent in patients with, compared to those without, objective clinical criteria of SOD (7/14 vs 0/13, P = 0.003). Phase III abnormality also tended to be more frequent in these patients (7/14 vs 2/13, P = 0.06). In addition, both phase III (P = 0.03) and phase II (P = 0.03) motility index (MI) was higher in patients with sphincter dyskinesia compared to controls; phase II MI was also higher in patients with sphincter stenosis (P = 0.005). Disturbances of small bowel interdigestive motor activity are more prevalent in postcholecystectomy patients with, compared to those without, objective evidence of SOD, and especially in patients with SO dyskinesia. Postcholecystectomy SOD in some patients may thus represent a component of a more generalized intestinal motor disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246055     DOI: 10.1023/a:1018879029855

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Sphincter of Oddi regulates flow by acting as a variable resistor to flow.

Authors:  Y F Liu; G T Saccone; A Thune; R A Baker; J R Harvey; J Toouli
Journal:  Am J Physiol       Date:  1992-11

2.  Pancreatic polypeptide and intestinal migrating motor complex in humans. Effect of pancreaticobiliary secretion.

Authors:  C Owyang; S R Achem-Karam; A I Vinik
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

3.  Manometric disorders in patients with suspected sphincter of Oddi dysfunction.

Authors:  J Toouli; I C Roberts-Thomson; J Dent; J Lee
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

Review 4.  What is sphincter of Oddi dysfunction?

Authors:  J Toouli
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

5.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients.

Authors:  T L Peeters; G Vantrappen; J Janssens
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

6.  Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features.

Authors:  P R Evans; E J Bennett; Y T Bak; C C Tennant; J E Kellow
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

7.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

8.  Biliary pressure variation in coordination with migrating motor complex of duodenum in patients with cholecystectomy and effects of morphine and cerulein.

Authors:  Y Ogawa; M Tanaka
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

9.  Human fasting and postprandial sphincter of Oddi motility.

Authors:  C S Worthley; R A Baker; J Iannos; G T Saccone; J Toouli
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

10.  Relationship of sphincter of Oddi spike bursts to gastrointestinal myoelectric activity in conscious opossums.

Authors:  R Honda; J Toouli; W J Dodds; S Sarna; W J Hogan; Z Itoh
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  12 in total

1.  Biliary Tract Dysmotility.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

2.  Reversibility of central neuronal changes in patients recovering from gallbladder stones or acute cholecystitis.

Authors:  Daniel-W Kjaer; Marek Stawowy; Lars Arendt-Nielsen; Asbjorn-Mohr Drewes; Peter Funch-Jensen
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

3.  Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones.

Authors:  Xun Li; Kexiang Zhu; Lei Zhang; Wenbo Meng; Wence Zhou; Xiangliang Zhu; Bo Li
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 4.  Sphincter of Oddi dysfunction: managing the patient with chronic biliary pain.

Authors:  Lana Bistritz; Vincent G Bain
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 5.  Clinical aspects of sphincter of Oddi function and dysfunction.

Authors:  J Toouli; A Craig
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 6.  Sphincter of Oddi dysfunction: is there a role for medical therapy?

Authors:  Alexander Craig; James Toouli
Journal:  Curr Gastroenterol Rep       Date:  2002-04

7.  Sphincter of Oddi dysfunction in children.

Authors:  Moises Guelrud; Leonel Rodriguez
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 8.  Intestinal dysmotility and its relationship to sphincter of Oddi dysfunction.

Authors:  Claudia Sanmiguel; Edy E Soffer
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 9.  Biliary dyskinesia in the pediatric patient.

Authors:  Michael S Halata; Stuart H Berezin
Journal:  Curr Gastroenterol Rep       Date:  2008-06

10.  Relative effects of dihydropyridine L-type calcium channel antagonism on biliary, duodenal, and vascular tissues: an in vivo and in vitro analysis in Australian brush-tailed possum.

Authors:  A G Craig; A Tottrup; J Toouli; G T P Saccone
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.